MedPath
NMPA Approval

Budesonide Suspension for Inhalation

国药准字HJ20140474

November 30, 2023

H20140474

Drug Information

吸入用布地奈德混悬液

普米克令舒

吸入混悬液

2ml:0.5mg

化学药品

November 30, 2023

November 29, 2028

Company Information

Applicant Company

66 Talavera Road Macquarie Park NSW 2113 AUSTRALIA

Manufacturing Company

10-14 Khartoum Road, North Ryde, NSW 2113, Australia

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

吸入用布地奈德混悬液 - NMPA 批准文号 | MedPath